AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32943241 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 652
Study 35421949 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused Acceptance and Commitment Therapy (FACT-CP)
Number of subjects: 26
Study 35421949 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (ETAU)
Number of subjects: 26
Study 35233271 — intervention group
Group type: EXPERIMENTAL
Intervention: FES-cycling and standard treatment
Number of subjects: 25
Study 35233271 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulus FES-cycling and standard treatment
Number of subjects: 25
Study 35233271 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 25
Study 32071044 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin-PRINT-CFI
Number of subjects: 0
Study 32071044 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin-PRINT-IP
Number of subjects: 0
Study 35592817 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen
Number of subjects: 89
Study 35592817 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 89
Study 33099752 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropeginterferon alfa‐2b 350 μg (group 1)
Number of subjects: 62
Study 33099752 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropeginterferon alfa‐2b 450 μg (group 2)
Number of subjects: 62
Study 33099752 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN alfa‐2a 180 μg (group 3)
Number of subjects: 62
Study 33099752 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 62
Study 34004418 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulforaphane (30 mg/d)
Number of subjects: 10
Study 34004418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 36111547 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence Club (AC)
Number of subjects: 409
Study 36111547 — intervention group
Group type: COMPARATOR
Intervention: Routine PHC clinics (Control)
Number of subjects: 409
Study 33963594 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week multimodal intervention (ATENTO) prior to adjuvant chemotherapy (ATENTO-B)
Number of subjects: 56
Study 33963594 — intervention group
Group type: COMPARATOR
Intervention: 8-week multimodal intervention (ATENTO) throughout adjuvant chemotherapy (ATENTO-T)
Number of subjects: 56
Study 35732186 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV/ΔNS2/Δ1313/I1314L (106 PFU)
Number of subjects: 0
Study 35732186 — intervention group
Group type: EXPERIMENTAL
Intervention: RSV/276 (105 PFU)
Number of subjects: 0
Study 35732186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34556547 — intervention group
Group type: EXPERIMENTAL
Intervention: Link for Injured Kids (Link)
Number of subjects: 314
Study 34556547 — intervention group
Group type: COMPARATOR
Intervention: Trauma Education
Number of subjects: 314
Study 32268973 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid hemorrhage (SAH)
Number of subjects: 21600
Study 32268973 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracerebral hemorrhage (ICH)
Number of subjects: 21600
Study 34763599 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-stable carbetocin 100 μg IM
Number of subjects: 1799
Study 34763599 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin 10 IU IM
Number of subjects: 1799
Study 33196553 — intervention group
Group type: EXPERIMENTAL
Intervention: Heplisav-B
Number of subjects: 64
Study 35719196 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodynamic technique (NT) with tendon gliding exercises (TGE)
Number of subjects: 30
Study 35719196 — intervention group
Group type: COMPARATOR
Intervention: Carpal bone mobilization technique (CBMT) with tendon gliding exercises (TGE)
Number of subjects: 30
Study 34933316 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine in 70% alcohol
Number of subjects: 482
Study 34933316 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone‐iodine in 70% alcohol
Number of subjects: 482
Study 34933316 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone‐iodine in aqueous solution
Number of subjects: 482
Study 35476508 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT/nivolumab
Number of subjects: 84
Study 35476508 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT/nivolumab/ipilimumab
Number of subjects: 84
Study 32220595 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1 mg/mL solution in Mucolox (arm A)
Number of subjects: 24
Study 32220595 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 0.1 mg/mL solution alone (arm B)
Number of subjects: 24
Study 36301019 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (25 µg) with 0.5% hyperbaric bupivacaine (3 mL)
Number of subjects: 60
Study 36301019 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine (0.8 mg) with 0.5% hyperbaric bupivacaine (3 mL)
Number of subjects: 60
Study 33278844 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper slope positions
Number of subjects: 179
Study 33278844 — intervention group
Group type: COMPARATOR
Intervention: Lower slope positions
Number of subjects: 179
Study 33278844 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional trait diversity
Number of subjects: 179
Study 33278844 — intervention group
Group type: EXPERIMENTAL
Intervention: Species identity and phylogeny
Number of subjects: 179
Study 32185388 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS
Number of subjects: 120
Study 32185388 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 120
Study 32185388 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS and 20 Hz rTMS
Number of subjects: 120
Study 32185388 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 120
Study 34627145 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation letter
Number of subjects: 3513
Study 34627145 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone call
Number of subjects: 3513
Study 34627145 — intervention group
Group type: COMPARATOR
Intervention: SMS
Number of subjects: 3513
Study 34627145 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitation letter plus introduction video
Number of subjects: 3513
Study 34627145 — intervention group
Group type: COMPARATOR
Intervention: Invitation letter only
Number of subjects: 3513
Study 35707866 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tomato extract supplement containing lycopene 30 mg
Number of subjects: 62
Study 35707866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 34835953 — intervention group
Group type: EXPERIMENTAL
Intervention: TLE (8 h eating/16 h fasting, 5 days per week) + blinded CGM
Number of subjects: 50
Study 34835953 — intervention group
Group type: COMPARATOR
Intervention: Prolonged eating window (12 h eating/12 h fasting) + blinded CGM
Number of subjects: 50
Study 34835953 — intervention group
Group type: EXPERIMENTAL
Intervention: TLE + real-time CGM feedback
Number of subjects: 50
Study 32504272 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 45
Study 32504272 — intervention group
Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 45
Study 32504272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 45
Study 32504272 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 45
Study 35090517 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance Exercise Assist Robot (BEAR) training combined with conventional inpatient rehabilitation
Number of subjects: 60
Study 35090517 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive balance training (IBT) combined with conventional inpatient rehabilitation
Number of subjects: 60
Study 35090517 — intervention group
Group type: COMPARATOR
Intervention: Conventional inpatient rehabilitation only (CR)
Number of subjects: 60
Study 33689553 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiobook Group (n = 12)
Number of subjects: 20
Study 33689553 — intervention group
Group type: COMPARATOR
Intervention: Comparison Group (n = 8)
Number of subjects: 20
Study 32329089 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG biofeedback (BF) training during daytime, with feedback alert signals for excessive EMG activity
Number of subjects: 17
Study 32329089 — intervention group
Group type: COMPARATOR
Intervention: Control group (CO) with no feedback during EMG recording sessions
Number of subjects: 17
Study 35344031 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion of freshly irradiated RBCs
Number of subjects: 42
Study 35344031 — intervention group
Group type: COMPARATOR
Intervention: Transfusion of irradiated and stored RBCs
Number of subjects: 42
Study 33482896 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway-driven eHealth-based integrated care model (PEICM) with full access to the telehealth system.
Number of subjects: 402
Study 33482896 — intervention group
Group type: COMPARATOR
Intervention: Control group using the mobile device only for BP measurement and receiving regular follow-ups.
Number of subjects: 402
Study 32645144 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in aerosol-generating procedures (AGP)
Number of subjects: 4689
Study 32645144 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 4689
Study 34444764 — intervention group
Group type: EXPERIMENTAL
Intervention: Mangosteen and propolis extracts (MAEC) - daily intake of a single capsule containing 194 mg for eight weeks
Number of subjects: 104
Study 34444764 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 104
Study 34444764 — intervention group
Group type: EXPERIMENTAL
Intervention: Mangosteen and propolis extracts (MAEC)
Number of subjects: 104
Study 33292205 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous care intervention (CCI) - very low carbohydrate diet inducing nutritional ketosis for 2 years
Number of subjects: 194
Study 33292205 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous care intervention (CCI)
Number of subjects: 194
Study 33292205 — intervention group
Group type: COMPARATOR
Intervention: Continuous care intervention (CCI) and usual care (UC)
Number of subjects: 194
Study 35568270 — intervention group
Group type: EXPERIMENTAL
Intervention: Distanced self-talk
Number of subjects: 67
Study 35568270 — intervention group
Group type: COMPARATOR
Intervention: Detached reappraisal
Number of subjects: 67
Study 33258774 — intervention group
Group type: EXPERIMENTAL
Intervention: Super high-pressure balloon
Number of subjects: 74
Study 33258774 — intervention group
Group type: COMPARATOR
Intervention: Scoring balloon
Number of subjects: 74
Study 32252241 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU/day vitamin D3
Number of subjects: 70
Study 32252241 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/day vitamin D3
Number of subjects: 70
Study 32252241 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU/day vitamin D3
Number of subjects: 70
Study 32252241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35960141 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-only (group A)
Number of subjects: 168
Study 35960141 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture with additional manual-movement or mind–body CIM therapies (group B)
Number of subjects: 168
Study 35960141 — intervention group
Group type: COMPARATOR
Intervention: Standard care (controls)
Number of subjects: 168
Study 33794975 — intervention group
Group type: COMPARATOR
Intervention: No intervention (CON)
Number of subjects: 80
Study 33794975 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (DCON)
Number of subjects: 80
Study 33794975 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention and supervised moderate volume exercise (MED)
Number of subjects: 80
Study 33794975 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention and supervised high volume exercise (HED)
Number of subjects: 80
Study 33156120 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 97
Study 33156120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 32576243 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 90
Study 32576243 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 90
Study 32576243 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group
Number of subjects: 90
Study 32412314 — intervention group
Group type: COMPARATOR
Intervention: 5% minoxidil twice daily for 24 weeks
Number of subjects: 71
Study 32412314 — intervention group
Group type: COMPARATOR
Intervention: Microneedle therapy every 3 weeks for eight treatments
Number of subjects: 71
Study 32412314 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of microneedling and 5% minoxidil for a total of 24 weeks
Number of subjects: 71
Study 32186395 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI + mucolytics
Number of subjects: 116
Study 32186395 — intervention group
Group type: COMPARATOR
Intervention: PPI only
Number of subjects: 116
Study 35332542 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)-based group counseling
Number of subjects: 63
Study 35332542 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 63
Study 32157433 — intervention group
Group type: EXPERIMENTAL
Intervention: 177-lutetium DOTATATE (LuDO) molecular radiotherapy, 75 to 100 MBq kg-1 per course, up to four courses, spaced at 8- to 12-week intervals
Number of subjects: 21
Study 35798520 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 100
Study 35798520 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPV23)
Number of subjects: 100
Study 35798520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35798520 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental human pneumococcal challenge (EHPC)
Number of subjects: 100
Study 33434956 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 119
Study 33434956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 33350366 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperonyl butoxide (PBO) long-lasting insecticidal nets (LLINs)
Number of subjects: 0
Study 33350366 — intervention group
Group type: COMPARATOR
Intervention: Conventional long-lasting insecticidal nets (LLINs)
Number of subjects: 0
Study 35964122 — intervention group
Group type: EXPERIMENTAL
Intervention: Open hemorrhoidectomy under local anesthesia
Number of subjects: 58
Study 35964122 — intervention group
Group type: COMPARATOR
Intervention: Saddle block
Number of subjects: 58
Study 34025683 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastiha supplementation (2.1 g/day) for 6 months
Number of subjects: 98
Study 34025683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 32235883 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26, modified vaccinia Ankara vectors containing mosaic HIV‐1 antigens
Number of subjects: 26
Study 32235883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 35939114 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced CT radiomics model (ERM)
Number of subjects: 123
Study 35939114 — intervention group
Group type: COMPARATOR
Intervention: Plain CT radiomics model (PRM)
Number of subjects: 123
Study 35939114 — intervention group
Group type: COMPARATOR
Intervention: Subjective image model (SIM)
Number of subjects: 123
Study 35939114 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model (CM)
Number of subjects: 123
Study 33471961 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher milk and dairy products intake
Number of subjects: 6744
Study 33471961 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower milk consumption (<220 g/day)
Number of subjects: 6744
Study 33471961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented dairy products intake
Number of subjects: 6744
Study 33471961 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole milk consumption
Number of subjects: 6744
Study 32627052 — intervention group
Group type: EXPERIMENTAL
Intervention: High flavanol (HF) chocolate bar (1060 mg)
Number of subjects: 15
Study 32627052 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate flavanol (MF) chocolate bar (746 mg)
Number of subjects: 15
Study 32627052 — intervention group
Group type: EXPERIMENTAL
Intervention: Low flavanol (LF) chocolate bar (406 mg)
Number of subjects: 15
Study 32627052 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) chocolate bar (88 mg)
Number of subjects: 15
Study 32627052 — intervention group
Group type: EXPERIMENTAL
Intervention: All flavanol concentrations
Number of subjects: 15
Study 32627052 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher flavanol concentrations
Number of subjects: 15
Study 35974700 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (SWL)
Number of subjects: 613
Study 35974700 — intervention group
Group type: COMPARATOR
Intervention: Ureteroscopic retrieval (URS)
Number of subjects: 613
Study 32996156 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium bifidum TMC3115
Number of subjects: 256
Study 32996156 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 256
Study 36380210 — intervention group
Group type: EXPERIMENTAL
Intervention: Spleen to non-cancerous liver volume ratio (STnLR)
Number of subjects: 0
Study 36380210 — intervention group
Group type: EXPERIMENTAL
Intervention: Spleen volume
Number of subjects: 0
Study 36380210 — intervention group
Group type: EXPERIMENTAL
Intervention: Spleen to liver volume ratio (STLR)
Number of subjects: 0
Study 36380210 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspartate aminotransferase to platelet ratio index (APRI)
Number of subjects: 0
Study 36380210 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrosis index based on the four factors (FIB-4)
Number of subjects: 0
Study 32538286 — intervention group
Group type: EXPERIMENTAL
Intervention: Full body compression garment (FBCG) worn for 24 hours post-race
Number of subjects: 32
Study 32538286 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FBCG)
Number of subjects: 32
Study 32538286 — intervention group
Group type: EXPERIMENTAL
Intervention: Full body compression garment (FBCG)
Number of subjects: 32
Study 32541370 — intervention group
Group type: EXPERIMENTAL
Intervention: Citicoline eyedrops 3 times daily for 3 years
Number of subjects: 80
Study 32541370 — intervention group
Group type: COMPARATOR
Intervention: Placebo 3 times daily for 3 years
Number of subjects: 80
Study 34859541 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium intensity odours
Number of subjects: 22
Study 34859541 — intervention group
Group type: COMPARATOR
Intervention: Odourless control stimulus
Number of subjects: 22
Study 32367180 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m2, four weekly infusions)
Number of subjects: 59
Study 34535609 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone Acetonide (TAA)
Number of subjects: 260
Study 34535609 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone Propionate (FP)
Number of subjects: 260
Study 34196632 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia Psychotherapy (with psycho-pharmacological therapy)
Number of subjects: 36
Study 34196632 — intervention group
Group type: COMPARATOR
Intervention: Psycho-pharmacological therapy and Multimedia Psychotherapy
Number of subjects: 36
Study 35754298 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab, trastuzumab, and physician's choice chemotherapy (PTC)
Number of subjects: 219
Study 35754298 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab and physician's choice chemotherapy (TC)
Number of subjects: 219
Study 34295147 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab biosimilar
Number of subjects: 159
Study 34295147 — intervention group
Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 159
Study 35164721 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth-only arm (interactive age-tailored prevention program delivered in 10 weekly, 90-min sessions on self-care behaviors, media literacy, self-esteem, and positive body image)
Number of subjects: 418
Study 35164721 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth & parental component arm (includes the same youth program plus parental updates and shared assignments via WhatsApp or smartphone application)
Number of subjects: 418
Study 35164721 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp mode for parental updates and assignments
Number of subjects: 418
Study 35164721 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth-only program delivered via smartphone application
Number of subjects: 418
Study 35164721 — intervention group
Group type: COMPARATOR
Intervention: Control group (received three health- and nutrition-related sessions)
Number of subjects: 418
Study 34328695 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position ventilation (PPV)
Number of subjects: 80
Study 34328695 — intervention group
Group type: COMPARATOR
Intervention: Supine position ventilation (SPV)
Number of subjects: 80
Study 32237292 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2550
Study 32237292 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 2550
Study 32237292 — intervention group
Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 2550
Study 32237292 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 2550
Study 32237292 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 2550
Study 32237292 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 2550
Study 32237292 — intervention group
Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 2550
Study 35131154 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS)
Number of subjects: 40
Study 35131154 — intervention group
Group type: COMPARATOR
Intervention: Vagus Nerve Isolation (VNI)
Number of subjects: 40
Study 34222067 — intervention group
Group type: EXPERIMENTAL
Intervention: NEP (diabetes nutrition education program)
Number of subjects: 77